Your browser doesn't support javascript.
loading
The identification and optimisation of novel and selective diamide neuropeptide Y Y2 receptor antagonists.
Lunniss, Gillian E; Barnes, Ashley A; Barton, Nick; Biagetti, Matteo; Bianchi, Federica; Blowers, Stephen M; Caberlotto, Laura; Emmons, Amanda; Holmes, Ian P; Montanari, Dino; Norris, Ros; Walters, Dewi J; Watson, Steve P.
Affiliation
  • Lunniss GE; GlaxoSmithKline, Neurosciences Centre of Excellence for Drug Discovery, New Frontiers Science Park, Harlow, UK.
Bioorg Med Chem Lett ; 19(15): 4022-5, 2009 Aug 01.
Article in En | MEDLINE | ID: mdl-19581086
ABSTRACT
A novel small molecule NPY Y2 antagonist (3) identified from high throughput screening is described. A subsequent SAR study and optimisation programme based around this molecule is also described, leading to the identification of potent and soluble pyridyl analogue 36.
Subject(s)

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Arginine / Benzazepines / Receptors, Neuropeptide Y / Amides Type of study: Diagnostic_studies Limits: Animals / Humans Language: En Journal: Bioorg Med Chem Lett Journal subject: BIOQUIMICA / QUIMICA Year: 2009 Type: Article Affiliation country: United kingdom

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Arginine / Benzazepines / Receptors, Neuropeptide Y / Amides Type of study: Diagnostic_studies Limits: Animals / Humans Language: En Journal: Bioorg Med Chem Lett Journal subject: BIOQUIMICA / QUIMICA Year: 2009 Type: Article Affiliation country: United kingdom